Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-01
2005-03-01
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S408000, C514S415000, C514S456000, C514S319000, C514S322000, C514S327000, C546S199000, C546S201000, C548S452000, C548S465000, C548S469000, C548S486000, C549S396000
Reexamination Certificate
active
06861418
ABSTRACT:
The present invention relates to 4-arylindolinones, as well as pharmaceutical compositions thereof, capable of modulating protein kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. The present invention also relates to methods for treating protein kinase related disorders.
REFERENCES:
patent: 5792783 (1998-08-01), Tang et al.
patent: 6114371 (2000-09-01), Tang et al.
patent: 6147106 (2000-11-01), Hirth et al.
patent: WO 94 03427 (1994-02-01), None
patent: WO 96 40116 (1996-12-01), None
patent: WO 98 50356 (1998-11-01), None
patent: WO 99 61422 (1999-12-01), None
patent: WO 00 08202 (2000-02-01), None
patent: WO 00 35908 (2000-06-01), None
patent: WO 00 35909 (2000-06-01), None
patent: 2000003509 (2000-06-01), None
patent: 2000035909 (2000-06-01), None
patent: WO 2001037820 (2001-05-01), None
patent: WO 01 49287 (2001-07-01), None
patent: WO 2001060814 (2001-08-01), None
patent: WO 01 94312 (2001-12-01), None
patent: WO 02 02551 (2002-01-01), None
Chemical Abstract DN 133:43433, also cited as WO 2000035909 dated Jun. 2000.*
Chem. Abstract DN 135:195497, pp. 121-130 of Search for US Sr. No. 10023488.12 = WO2001060814, (2001).
Chem. Abstract DN 2001037820, pp. 131-139 of search for US Sr. No. 10023488.12 = WO2001037820, (2001).
Chemical Abstract DN 133:43433, also cited as WO 2000035909, (2000).
Chu Ji Yu
Cui Jingrong
Do Steven Huy
Koenig Marcel
Li Xiaoyuan
Burrous Beth A.
Patel Sudhaker B.
Raymond Richard L.
Sugen Inc.
LandOfFree
4-aryl substituted indolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aryl substituted indolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aryl substituted indolinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3451902